Digitalisering as a prescription for competitive power
Is your digital infrastructure still in line with your business model?
Find out if the continuity of your business is sufficiently guaranteed by using the Digiscan or contact us for a consultation.
Digitalization across the value chain is helping the pharmaceutical industry accelerate the process of getting products from the lab to the patients. New technologies such as artificial intelligence (AI) and robotics are reducing the production cycle and contributing to more efficient production and processes. Collaborative research and development partnerships, which have emerged in part due to the coronavirus pandemic, are becoming the norm among industries and enterprises. Digital transformation will help you make your organization more competitive – and healthier.
The added value of digital transformation for pharma
Digitalization and automation in the pharmaceutical industry have primarily emerged in response to growing competition in China and India. Market shares are gradually shifting toward Asia and margins in Western countries have come under pressure. To stay ahead of the competition and reduce costs, automation and digitalization have become the logical next step. Consistently high quality and compliance with Good Manufacturing Practices (GMP) and all legal requirements are essential in this regard. Other trends that are happening in your industry:
Trend #1: Technological innovation in supply chains
As new technologies take the pharmaceutical industry by storm, drug development processes and the entire supply chain are being redesigned. High-tech medical distribution helps medications reach patients faster. Blockchain technology also provides security in the supply chain, now that pharmaceutical products can be tracked in real time.
Trend #2: More flexible product strategies
The biopharmaceutical sector faces an increasing need for more flexibility with simplified manufacturing strategies. One of the growth areas is the application of single-use technology. Collaborating contract manufacturers are also increasing in number. These facilities must be flexible enough to produce multiple drugs to meet industry demand.
Trend #3: AI-driven efficiency
Artificial intelligence is driving efficiency in every sector, and the pharmaceutical industry is no exception. Just look at the shorter production cycle and more efficient manufacturing and processes. In the healthcare sector, AI is already helping with diagnostics, treatment design, robot-assisted surgery and many other medical needs.
Your challenges, our solutions
How does your pharmaceutical company gain a competitive edge? How do you acquire a larger market share? A streamlined digital transformation is a key ally. Especially in the challenges that pharmaceutical companies are likely to be facing:
Lack of digital expertise
The digitalization of internal and external processes requires skilled technical personnel that many organizations are lacking. At the same time, the demand for skilled, experienced ICT specialists is high and competition is fiercer than ever.
Certifications: the regulatory framework
The European Union has a robust legal framework in place to protect public health and guarantee the safety of products and devices. As a pharmaceutical company, you will have to continuously adapt to changing laws and regulations.
Your partner in a successful digital transformation
Digital transformation hinges on good preparation. As a pharmaceutical company, it makes sense to start by developing a sustainable digital strategy and only then contemplate the technology that can contribute to it. We are the partner who can advise you throughout the entire process. We will help you find the right solutions and guide you through every step of your digital transformation. In this process, you can rely on our years of experience and expertise.
Would you like to get autonomous and personal advice?
Then I would gladly assist you further.